Carcinoembryonic Antigen Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the carcinoembryonic antigen market (CEA) looks promising with opportunities in colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, and thyroid cancer. The global carcinoembryonic antigen market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases and growing demand for minimally invasive diagnostic procedures in cancer.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global carcinoembryonic antigen market report, please download the report brochure.
In this market, colorectal cancer is the largest application of carcinoembryonic, whereas hospitals is the largest end user. Growth in various segments of the carcinoembryonic market are given below:
The study includes trends and forecast for the global carcinoembryonic antigen market by application, end user, and region as follows:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Centers
Cancer Centers
Research Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the carcinoembryonic antigen model companies profiled in this report includes Roche, Quest Diagnostics, GenWay Biotech, Correlogic Systems, Creative Diagnostics, Omega Diagnostics Group, RayBiotech, and Boster Biological Technology.
Lucintel forecasts that colorectal cancer will remain the largest application segment over the forecast period due to increasing demand for minimally invasive diagnostic procedures, growing geriatric population base, and the increasing prevalence of unhealthy lifestyles, such as irregular dietary habits and exposure to carcinogenic elements.
Within this market, hospitals will remain the largest end user segment over the forecast period due to the presence of favorable government initiatives pertaining to cancer awareness and control by organizations, such as the Cancer Prevention and Control Research Network (CPCRN) and the National Cancer Institute.
North America will remain the largest region over the forecast period due to high incidence rates of cancers, presence of sophisticated healthcare infrastructure, and high patient awareness levels coupled with relatively higher healthcare expenditure levels in the region.
Features of the Global Carcinoembryonic Antigen Market
Market Size Estimates: Global carcinoembryonic antigen market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global carcinoembryonic antigen market size by various segments, such as application and end user in terms of value.Regional Analysis: Global carcinoembryonic antigen market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different application, end user, and region for the global carcinoembryonic antigen market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global carcinoembryonic antigen market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global carcinoembryonic antigen market by application (colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, and thyroid cancer), end user (hospitals, diagnostic centers, cancer centers, and research centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global carcinoembryonic antigen market?
Q.5 What are the business risks and threats to the global carcinoembryonic antigen market?
Q.6 What are the emerging trends in this carcinoembryonic antigen market and the reasons behind them?
Q.7 What are some changing demands of customers in this carcinoembryonic antigen market?
Q.8 What are the new developments in this carcinoembryonic antigen market? Which companies are leading these developments?
Q.9 Who are the major players in this carcinoembryonic antigen market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this carcinoembryonic antigen market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global carcinoembryonic antigen market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Application (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, and Thyroid Cancer) and End User (Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the carcinoembryonic antigen market (CEA) looks promising with opportunities in colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, and thyroid cancer. The global carcinoembryonic antigen market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases and growing demand for minimally invasive diagnostic procedures in cancer.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global carcinoembryonic antigen market report, please download the report brochure.
In this market, colorectal cancer is the largest application of carcinoembryonic, whereas hospitals is the largest end user. Growth in various segments of the carcinoembryonic market are given below:
The study includes trends and forecast for the global carcinoembryonic antigen market by application, end user, and region as follows:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Centers
Cancer Centers
Research Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the carcinoembryonic antigen model companies profiled in this report includes Roche, Quest Diagnostics, GenWay Biotech, Correlogic Systems, Creative Diagnostics, Omega Diagnostics Group, RayBiotech, and Boster Biological Technology.
Lucintel forecasts that colorectal cancer will remain the largest application segment over the forecast period due to increasing demand for minimally invasive diagnostic procedures, growing geriatric population base, and the increasing prevalence of unhealthy lifestyles, such as irregular dietary habits and exposure to carcinogenic elements.
Within this market, hospitals will remain the largest end user segment over the forecast period due to the presence of favorable government initiatives pertaining to cancer awareness and control by organizations, such as the Cancer Prevention and Control Research Network (CPCRN) and the National Cancer Institute.
North America will remain the largest region over the forecast period due to high incidence rates of cancers, presence of sophisticated healthcare infrastructure, and high patient awareness levels coupled with relatively higher healthcare expenditure levels in the region.
Features of the Global Carcinoembryonic Antigen Market
Market Size Estimates: Global carcinoembryonic antigen market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global carcinoembryonic antigen market size by various segments, such as application and end user in terms of value.Regional Analysis: Global carcinoembryonic antigen market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different application, end user, and region for the global carcinoembryonic antigen market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global carcinoembryonic antigen market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global carcinoembryonic antigen market by application (colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, and thyroid cancer), end user (hospitals, diagnostic centers, cancer centers, and research centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global carcinoembryonic antigen market?
Q.5 What are the business risks and threats to the global carcinoembryonic antigen market?
Q.6 What are the emerging trends in this carcinoembryonic antigen market and the reasons behind them?
Q.7 What are some changing demands of customers in this carcinoembryonic antigen market?
Q.8 What are the new developments in this carcinoembryonic antigen market? Which companies are leading these developments?
Q.9 Who are the major players in this carcinoembryonic antigen market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this carcinoembryonic antigen market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global carcinoembryonic antigen market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Application (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, and Thyroid Cancer) and End User (Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Carcinoembryonic Antigen Market Trends and Forecast
3.3: Global Carcinoembryonic Antigen Market by Application
3.3.1: Colorectal Cancer
3.3.2: Pancreatic Cancer
3.3.3: Ovarian Cancer
3.3.4: Breast Cancer
3.3.5: Thyroid Cancer
3.4: Global Carcinoembryonic Antigen Market by End User
3.4.1: Hospitals
3.4.2: Diagnostic Centers
3.4.3: Cancer Centers
3.4.4: Research Centers
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Carcinoembryonic Antigen Market by Region
4.2: North American Carcinoembryonic Antigen Market
4.2.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.2.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.2.3: The United States Carcinoembryonic Antigen Market
4.2.4: The Canadian Carcinoembryonic Antigen Market
4.2.5: The Mexican Carcinoembryonic Antigen Market
4.3: European Carcinoembryonic Antigen Market
4.3.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.3.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.3.3: The United Kingdom Carcinoembryonic Antigen Market
4.3.4: The Spanish Carcinoembryonic Antigen Market
4.3.5: The German Carcinoembryonic Antigen Market
4.3.6: The French Carcinoembryonic Antigen Market
4.4: APAC Carcinoembryonic Antigen Market
4.4.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.4.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.4.3: The Chinese Carcinoembryonic Antigen Market
4.4.4: The Indian Carcinoembryonic Antigen Market
4.4.5: The Japanese Carcinoembryonic Antigen Market
4.5: ROW Carcinoembryonic Antigen Market
4.5.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.5.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.5.3: Brazilian Carcinoembryonic Antigen Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Carcinoembryonic Antigen Market by Application
7.1.2: Growth Opportunities for the Global Carcinoembryonic Antigen Market by End User
7.1.3: Growth Opportunities for the Global Carcinoembryonic Antigen Market by Region
7.2: Emerging Trends in the Global Carcinoembryonic Antigen Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Carcinoembryonic Antigen Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Carcinoembryonic Antigen Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd
8.2: Quest Diagnostics
8.3: GenWay Biotech Inc.
8.4: Correlogic Systems, Inc.
8.5: Creative Diagnostics
8.6: Omega Diagnostics Group PLC
8.7: RayBiotech, Inc
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Carcinoembryonic Antigen Market Trends and Forecast
3.3: Global Carcinoembryonic Antigen Market by Application
3.3.1: Colorectal Cancer
3.3.2: Pancreatic Cancer
3.3.3: Ovarian Cancer
3.3.4: Breast Cancer
3.3.5: Thyroid Cancer
3.4: Global Carcinoembryonic Antigen Market by End User
3.4.1: Hospitals
3.4.2: Diagnostic Centers
3.4.3: Cancer Centers
3.4.4: Research Centers
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Carcinoembryonic Antigen Market by Region
4.2: North American Carcinoembryonic Antigen Market
4.2.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.2.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.2.3: The United States Carcinoembryonic Antigen Market
4.2.4: The Canadian Carcinoembryonic Antigen Market
4.2.5: The Mexican Carcinoembryonic Antigen Market
4.3: European Carcinoembryonic Antigen Market
4.3.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.3.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.3.3: The United Kingdom Carcinoembryonic Antigen Market
4.3.4: The Spanish Carcinoembryonic Antigen Market
4.3.5: The German Carcinoembryonic Antigen Market
4.3.6: The French Carcinoembryonic Antigen Market
4.4: APAC Carcinoembryonic Antigen Market
4.4.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.4.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.4.3: The Chinese Carcinoembryonic Antigen Market
4.4.4: The Indian Carcinoembryonic Antigen Market
4.4.5: The Japanese Carcinoembryonic Antigen Market
4.5: ROW Carcinoembryonic Antigen Market
4.5.1: Market by Product: Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, and Others Products
4.5.2: Market by End User: Hospitals, Diagnostic Centers, Cancer Centers, and Research Centers
4.5.3: Brazilian Carcinoembryonic Antigen Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Carcinoembryonic Antigen Market by Application
7.1.2: Growth Opportunities for the Global Carcinoembryonic Antigen Market by End User
7.1.3: Growth Opportunities for the Global Carcinoembryonic Antigen Market by Region
7.2: Emerging Trends in the Global Carcinoembryonic Antigen Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Carcinoembryonic Antigen Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Carcinoembryonic Antigen Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd
8.2: Quest Diagnostics
8.3: GenWay Biotech Inc.
8.4: Correlogic Systems, Inc.
8.5: Creative Diagnostics
8.6: Omega Diagnostics Group PLC
8.7: RayBiotech, Inc
8.8: Company
8.9: Company
8.10: Company
